Benzinga investigated the prospects for the favorite shares of many investors in the past week – here is a look at some of our top stories. Escalating tensions between Israel and Iran and President Donald Trump‘s renewed attacks on Fed Chair Jerome PowellUneasy markets this week. The Federal Reserve kept rates at 4.25-4.5%, reduced the […]
Aptevo Therapeutics Inc APVO The shares rise on Wednesday. According to data from Benzinga Pro, the share is higher with a strong volume of 81.8 million compared to the average volume of 275.3k. What happened: Aptevo revealed new clinical data from the current phase 1b/2 Rainier study for evaluation of mipletamig, the first-in-class CD123 x […]